Terms: = Ovarian germ cell tumor AND BRCA2, FAD, 675, ENSG00000139618, FACD, FAD1, FANCD, FANCD1, BRCC2, RP11-298P3_4 AND Prognosis
230 results:
1. A Multi-Center, Multi-Parametric MRI Dataset of Primary and Secondary Brain tumors.
Gong Z; Xu T; Peng N; Cheng X; Niu C; Wiestler B; Hong F; Li HB
Sci Data; 2024 Jul; 11(1):789. PubMed ID: 39019912
[TBL] [Abstract] [Full Text] [Related]
2. Challenges in the diagnosis and treatment of pure non-gestational uterine choriocarcinoma in a child: a case report.
Darmawan F; Fauzi AR; Pratignyo RB; Kumaladewi P; Rahmadanty AE; Santhony AN; Rinonce HT; Gunadi
J Med Case Rep; 2024 Jul; 18(1):323. PubMed ID: 39004746
[TBL] [Abstract] [Full Text] [Related]
3. [The clinical characteristics of metastatic tumors in small intestine].
Dong XY; Li YL; Yao JN; Zhang LF
Zhonghua Yi Xue Za Zhi; 2024 Jun; 104(21):2003-2006. PubMed ID: 38825945
[TBL] [Abstract] [Full Text] [Related]
4. Clinical Manifestations of Malignant Struma Ovarii: A Retrospective Case Series in a Tertiary Hospital in Korea.
Ryu HJ; Leem DE; Yoo JH; Kim TH; Kim SW; Chung JH
Endocrinol Metab (Seoul); 2024 Jun; 39(3):461-467. PubMed ID: 38721636
[TBL] [Abstract] [Full Text] [Related]
5. germline biallelic brca2 pathogenic variants and medulloblastoma: an international cohort study.
Kastellan S; Kalb R; Sajjad B; McReynolds LJ; Giri N; Samuel D; Milde T; Elbracht M; Holzhauer S; Niewisch MR; Kratz CP
J Hematol Oncol; 2024 Apr; 17(1):26. PubMed ID: 38685107
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Presentation, Management, and Diagnostic Performance of 2021 Criteria for Paraneoplastic Neurologic Syndromes in Childhood.
Zhou J; Jin M; Su Y; Zhuo X; Fu L; Ren X; Ren C; Zhou A; Li J; Zhang W
Neurol Neuroimmunol Neuroinflamm; 2024 May; 11(3):e200242. PubMed ID: 38657195
[TBL] [Abstract] [Full Text] [Related]
7. [Gonadoblastoma: Clinicopathological study and literature review of 3 cases].
Bao ML; Li X; Chen G; Li H; Chen W; Li HX
Zhonghua Nan Ke Xue; 2023 Jul; 29(7):634-638. PubMed ID: 38619412
[TBL] [Abstract] [Full Text] [Related]
8. [Clinical analysis of 12 cases of ovarian yolk sac tumor].
Liu J; Chu HJ; Shan YP; Song WJ; Chen AP
Zhonghua Fu Chan Ke Za Zhi; 2024 Mar; 59(3):210-214. PubMed ID: 38544450
[No Abstract] [Full Text] [Related]
9. [A pan-cancer analysis of TTC9A expression level and its correlation with prognosis and immune microenvironment].
Yao Y; Liu J; Zhou X; Liu Z; Qiu S; He Y; Zhou X
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jan; 44(1):70-82. PubMed ID: 38293978
[TBL] [Abstract] [Full Text] [Related]
10. Study of neoadjuvant chemotherapy in advanced malignant ovarian germ cell tumors at a tertiary center in western India.
Vasanth A; Patel SM; Arora R; Parekh CD; Dave P; Patel BM; Vemanamandhi P
J Gynecol Oncol; 2024 Mar; 35(2):e19. PubMed ID: 37921603
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic factors for pure ovarian immature teratoma and the role of adjuvant chemotherapy in stage I diseases.
Li S; Zhang X; Zhang T; Yin M; Cao D; Xiang Y; Yang J
Ann Med; 2023; 55(2):2273984. PubMed ID: 37909181
[TBL] [Abstract] [Full Text] [Related]
12. The tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers.
Oubaddou Y; Ben Ali F; Oubaqui FE; Qmichou Z; Bakri Y; Ameziane El Hassani R
Asian Pac J Cancer Prev; 2023 Sep; 24(9):3139-3153. PubMed ID: 37774066
[TBL] [Abstract] [Full Text] [Related]
13. The role of pediatric oncologist in prenatal diagnosis: A 10-year retrospective study at Assistance Publique Hôpitaux de Marseille (AP-HM).
Min V; Coze S; D'Ercole C; Panait N; Sigaudy S; Aschero A; Zattara H; Bretelle F; Revon-Riviere G; Coze C
Pediatr Hematol Oncol; 2024; 41(1):30-40. PubMed ID: 37599628
[TBL] [Abstract] [Full Text] [Related]
14. Recurrent squamous cell carcinoma arising in ovary mature cystic teratoma: A case report.
Ji X; Zhai P; Yang H; Wang H; Wang X
Medicine (Baltimore); 2023 Aug; 102(32):e34734. PubMed ID: 37565860
[TBL] [Abstract] [Full Text] [Related]
15. A 10-year clinicopathological analysis of ovarian lesions in a tertiary hospital in Southern Nigeria.
Abasiattai AM; Nwafor CC; Utuk NM
Afr Health Sci; 2023 Mar; 23(1):459-468. PubMed ID: 37545925
[TBL] [Abstract] [Full Text] [Related]
16. Impacts of ovarian preservation on the prognosis of neuroendocrine cervical carcinoma: a retrospective analysis based on machine learning.
Xiang X; Zhang Y; Hua K; Ding J
World J Surg Oncol; 2023 May; 21(1):146. PubMed ID: 37173713
[TBL] [Abstract] [Full Text] [Related]
17. Fertility and prognosis assessment between bleomycin/etoposide/cisplatin and paclitaxel/carboplatin chemotherapy regimens in the conservative treatment of malignant ovarian germ cell tumors: a multicenter and retrospective study.
Chu R; Liu P; Chen J; Cheng X; Li K; Che Y; Wang J; Li L; Zhang X; Yao S; Song L; Zhao Y; Huang C; Xue Y; Pan X; Li J; Chen Z; Jiang J; Kong B; Song K
J Gynecol Oncol; 2023 Mar; 34(2):e12. PubMed ID: 36890292
[TBL] [Abstract] [Full Text] [Related]
18. Assessment of prognostic and reproductive outcomes of omentectomy for patients with clinically apparent early-stage (I, II) malignant ovarian germ cell tumours: A multicentre retrospective study.
Liu P; Li Z; Cheng X; Gao Q; Che Y; Zhang Z; Chu R; Chen Z; Zhang Y; Wang Q; Dou Z; Wei Y; Cui Z; Wang J; Xie X; Ma D; Yang X; Kong B; Song K
BJOG; 2022 Nov; 129 Suppl 2():23-31. PubMed ID: 36485067
[TBL] [Abstract] [Full Text] [Related]
19. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
20. Clinical characteristics and survival outcomes in patients with ovarian strumal carcinoid.
Li S; Wang X; Sui X; Zhang X; Yin M; Yang J
BMC Cancer; 2022 Oct; 22(1):1090. PubMed ID: 36280824
[TBL] [Abstract] [Full Text] [Related]
[Next]
